AGRX Agile Therapeutics Inc.

3.63
-0.10  -3%
Previous Close 3.73
Open 3.75
Price To book 3.59
Market Cap 104567225
Shares 28,806,398
Volume 142,530
Short Ratio 1.71
Av. Daily Volume 320,982

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

CRL issued 2013. Phase 3 top-line data released January 3, 2017 - poor data. NDA resubmitted with PDUFA date of December 26, 2017
Twirla
Contraceptive patch

SEC Filings

  1. 8-K - Current report 171081417
  2. SC 13G - Statement of acquisition of beneficial ownership by individuals 171040948
  3. SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals 171007889
  4. 8-K - Current report 171005402
  5. 424B5 - Prospectus [Rule 424(b)(5)] 171005218
  6. 424B5 - Prospectus [Rule 424(b)(5)] 171001200
  7. 8-K - Current report 171000899
  8. 8-K - Current report 17990409
  9. 8-K - Current report 17987870
  10. 10-Q - Quarterly report [Sections 13 or 15(d)] 17987540